Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joseph Y. Chang Insider Profile
4 Followers
Joseph Y. Chang, CSO at Nu Skin, holds 99.30K shares in Nu Skin (Ticker: NUS), holds 184.61K shares in Optimer Pharma (Ticker: OPTR). Most recently, Joseph Y. Chang Sold ― shares of Nu Skin on Mar 03, 2023 for an estimated value of 3.79M.
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
+7.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
CSO
Roles that Joseph Y. Chang holds in companies
Most Profitable Insider Trade
The most profitable trade made by Joseph Y. Chang
Joseph Y. Chang's Trading History
Nu Skin
Mar 03, 2023
CSO
Informative Sell
3.79M
$1.26M
Optimer Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Joseph Y. Chang's performance on stock
You May Also Like
Joseph Y. Chang insider profile FAQ
What is the percentage of profitable transactions made by Joseph Y. Chang?
The percentage of profitable transactions made by Joseph Y. Chang is 50%.
What is the average return per transaction made by Joseph Y. Chang?
The average return per transaction made by Joseph Y. Chang is 7.60%.
What stocks does Joseph Y. Chang hold?
Joseph Y. Chang holds: NUS, OPTR stocks.
What was Joseph Y. Chang’s latest transaction?
Joseph Y. Chang latest transaction was an Informative Sell of $3.79M.
What was Joseph Y. Chang's most profitable transaction?
Joseph Y. Chang’s most profitable transaction was an Informative Sell of NUS stock on March 3, 2023. The return on the trade was 68.00%.
What is Joseph Y. Chang's role in Nu Skin?
Joseph Y. Chang's role in Nu Skin is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.